Anita Rovers
Anita is a part of our accounting team and primarily responsible for the statutory and US GAAP compliance of the European entities.
Candice Tam
Candice holds a MSc in Economic Evaluation in Healthcare from City, University of London. For her master’s thesis, she conducted an early cost-effectiveness analysis and targeted literature review in acute kidney injury. She has a pharmacist background, having graduated from a Master in Pharmacy from the University of East Anglia. As a Research Associate, she
Andreas Freitag
Andreas has extensive experience in systematic reviewing and (network) meta-analysis, as well as synthesising evidence in support of HTA submissions, through multiple roles in HEOR consulting, payer settings, and academia. He previously held a senior researcher position at the National Guideline Centre (NGC), commissioned by NICE, to develop clinical, social care, and service delivery guidelines
Alex (Chien) Tsai
Alex holds a BSc in Pharmacy from Taipei Medical University and a MSc in Health Economics and Decision Modelling from the University of Sheffield in the School of Health and Related Research (ScHARR). He is a registered Pharmacist in Taiwan. During his MSc degree, he incorporated a Distributional Cost-Effectiveness into Sheffield Tobacco Policy Model to
Susi Sadler
Susi has a Masters in Economic Management and Policy from the University of Strathclyde and a Bachelors in Anatomy and Physiology from the University of Leeds. She has worked in the field of health economics, with a focus on modelling, for over 7 years both in academic roles at the University of Sheffield and the
Rene Sweegers
Rene sets up and lead the European financial team and improve and standardize the financial end to end processes.
Lydia Vinals
Lydia is a Senior Research Consultant with experience in evidence synthesis activities including targeted reviews to inform early value frameworks and systematic reviews to support HTA submissions. She also has experience in conducting feasibility assessments for quantitative analyses including network meta-analyses, surrogate endpoint analyses, and post-hoc analyses of clinical trial data. As a consultant, Lydia
Maria Rizzo
Maria has a wealth of experience in global systematic literature reviews and strengthens the joint capabilities of Cytel and Ingress-Health in this field. As Senior Director HEOR, Maria leads projects from the United Kingdom.
